Atreon Orthopedics expands indications for Rotium bioabsorbable wick

Atreon Orthopedics earned expanded FDA 510(k) clearance for its Rotium bioreabsorbable wick, according to a March 6 news release. 

Advertisement

The implant is now indicated for all tendon repairs including Achilles, triceps, patellar quadricep and gluteus medius surgery. It can also be used in various foot and ankle surgeries.

Rotium has been used in more than 12,000 rotator cuff cases. It withstands moisture and suturing without wear, wicks biology at the repair site and is a cost-effective product.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.